Influence of Common Gene Variants on Lipid Levels and Risk of Coronary Heart Disease in Afro-Caribbeans

被引:0
|
作者
Larifla, Laurent [1 ,2 ,3 ]
Bassien-Capsa, Valerie [1 ]
Velayoudom, Fritz-Line [1 ,2 ]
Chingan-Martino, Vaneva [1 ]
Afassinou, Yaovi [1 ]
Ancedy, Yann [1 ,3 ]
Galantine, Olivier [1 ]
Galantine, Valerie [1 ]
Nicolas, Livy [1 ]
Martino, Frederique [1 ]
Numeric, Patrick [4 ]
Foucan, Lydia [1 ]
Humphries, Steve E. [5 ]
机构
[1] Univ Hosp Guadeloupe, Res Team Cardiometab Risk ECM RCM, F-97159 Pointe A Pitre, France
[2] Univ Antilles, Lab Math Informat & Applicat LAMIA, UR 1 1, F-97157 Pointe A Pitre, France
[3] Univ Hosp Guadeloupe, Dept Cardiol, F-97159 Pointe A Pitre, France
[4] Univ Hosp Martinique, Dept Rheumatol, F-97261 Fort De France, France
[5] UCL, Inst Cardiovasc Sci, Ctr Cardiovasc Genet, London WC1E 6JF, England
关键词
lipids; polygenic risk score; Afro-Caribbean; coronary artery disease; ETHNIC-DIFFERENCES; CARDIOVASCULAR RISK; BLOOD CHOLESTEROL; PLASMA-LIPIDS; BODY-FAT; ASSOCIATION; LOCI; HYPERTRIGLYCERIDEMIA; LIPOPROTEIN; POPULATION;
D O I
10.3390/ijms252011140
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A lower mortality rate from coronary artery disease (CAD) and a more favourable lipid profile have been reported in Afro-Caribbeans compared with people of European ancestry. The aim of this study was to determine whether common lipid variants identified in other populations are associated with lipid levels and CAD in Afro-Caribbeans. We studied 705 Afro-Caribbeans (192 with CAD) who were genotyped for 13 lipid-associated variants. We calculated three polygenic risk scores (PRSs) for elevated LDL (LDL-PRS), decreased HDL (HDL-PRS), and elevated triglycerides (TG-PRS). LDL-PRS, HDL-PRS, and TG-PRS were associated with LDL, HDL, and TG levels, respectively. The LDL-PRS was positively associated with LDL > 2.6 mmol/L and with LDL > 3.0 mmol/L with ORs (odds ratios) of 1.33 (95% confidence interval (CI) = 1.14-1.56) and 1.40 (CI = 1.21-1.62), respectively. The HDL-PRS was associated with a low HDL category (HDL < 1.03 mmol/L) with an OR of 1.3 (CI = 1.04-1.63) and inversely associated with a high HDL category (HDL > 1.55 mmol/L) with an OR of 0.79 (CI = 0.65-0.96). The LDL-PRS was positively associated with CAD after adjustment for age, gender, hypertension, diabetes, and smoking with an OR of 1.27 (CI = 1.06-1.51) but not the HDL-PRS nor the TG-PRS. Results of the present study indicate that common lipid variants are associated with lipid levels and prevalent CAD in Afro-Caribbeans.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Adiponectin gene variants and the risk of coronary heart disease: a 16-year longitudinal study
    Cheung, Chloe Y. Y.
    Hui, Elaine Y. L.
    Cheung, Bernard M. Y.
    Woo, Y. C.
    Xu, Aimin
    Fong, Carol H. Y.
    Ong, K. L.
    Yeung, C. Y.
    Janus, Edward D.
    Tse, Hung-Fat
    Sham, Pak C.
    Lam, Karen S. L.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2014, 171 (01) : 107 - 115
  • [33] Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts
    Aulchenko, Yurii S.
    Ripatti, Samuli
    Lindqvist, Ida
    Boomsma, Dorret
    Heid, Iris M.
    Pramstaller, Peter P.
    Penninx, Brenda W. J. H.
    Janssens, A. Cecile J. W.
    Wilson, James F.
    Spector, Tim
    Martin, Nicholas G.
    Pedersen, Nancy L.
    Kyvik, Kirsten Ohm
    Kaprio, Jaakko
    Hofman, Albert
    Freimer, Nelson B.
    Jarvelin, Marjo-Riitta
    Gyllensten, Ulf
    Campbell, Harry
    Rudan, Igor
    Johansson, Asa
    Marroni, Fabio
    Hayward, Caroline
    Vitart, Veronique
    Jonasson, Inger
    Pattaro, Cristian
    Wright, Alan
    Hastie, Nick
    Pichler, Irene
    Hicks, Andrew A.
    Falchi, Mario
    Willemsen, Gonneke
    Hottenga, Jouke-Jan
    de Geus, Eco J. C.
    Montgomery, Grant W.
    Whitfield, John
    Magnusson, Patrik
    Saharinen, Juha
    Perola, Markus
    Silander, Kaisa
    Isaacs, Aaron
    Sijbrands, Eric J. G.
    Uitterlinden, Andre G.
    Witteman, Jacqueline C. M.
    Oostra, Ben A.
    Elliott, Paul
    Ruokonen, Aimo
    Sabatti, Chiara
    Gieger, Christian
    Meitinger, Thomas
    NATURE GENETICS, 2009, 41 (01) : 47 - 55
  • [34] LIPID AND APOLIPOPROTEIN LEVELS IN SUBJECTS WITH CORONARY HEART-DISEASE
    BEIGEL, Y
    HEIBIG, G
    LUCK, J
    GOTTO, AM
    GHISELLI, G
    ARTERIOSCLEROSIS, 1985, 5 (05): : A517 - A517
  • [36] Common mutations in the lipoprotein lipase gene influence plasma lipids and prevalence of coronary heart disease
    Hayden, MR
    Gagne, SE
    Larson, MG
    Wittekoek, ME
    Pimstone, SN
    Schaefer, EJ
    Defesche, JC
    Wilson, PWF
    Kastelein, JJP
    Ordovas, JM
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 12 - 12
  • [37] Pharmacogenetics of apolipoprtein E gene during lipid-lowering therapy: lipid levels and prevention of coronary heart disease
    Nieminen, Tuomo
    Kahonen, Mika
    Viiri, Leena E.
    Gronroos, Paula
    Lehtimaki, Terho
    PHARMACOGENOMICS, 2008, 9 (10) : 1475 - 1486
  • [38] Influence of SCARB1 gene SNPs on serum lipid levels and susceptibility to coronary heart disease and cerebral infarction in a Chinese population
    Zeng, Ting-Ting
    Tang, Di-Jiao
    Ye, Yuan-Xin
    Su, Jun
    Jiang, Hong
    GENE, 2017, 626 : 319 - 325
  • [39] Lipoprotein(a) levels and risk of future coronary heart disease
    Bennet, Anna
    Di Angelantonio, Ernanuele
    Erqou, Sebhat
    Eiriksdottir, Gudny
    Sigurdsson, Gunnar
    Woodward, Mark
    Rumley, Ann
    Lowe, Gordon D. O.
    Danesh, John
    Gudnason, Vilmundur
    ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (06) : 598 - 608
  • [40] Changing Cholesterol Levels and Coronary Heart Disease Risk
    Wilson, Peter W. F.
    CIRCULATION, 2016, 133 (03) : 239 - 241